Lyell Immunopharma Inc
(LYEL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 293,828 | 393,504 | 564,441 | 0 | N/A |
| Marketable Securities | 320,966 | 225,417 | 260,082 | 0 | N/A |
| TOTAL | $626,286 | $631,147 | $834,840 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 120,098 | 115,857 | 109,637 | N/A | N/A |
| Investments And Advances | 330,532 | 400,959 | 233,709 | 0 | 0 |
| Other Non-Current Assets | 50,490 | 50,371 | 51,681 | 0 | 0 |
| TOTAL | $501,120 | $567,187 | $395,027 | $N/A | $N/A |
| Total Assets | $1,127,406 | $1,198,334 | $1,229,867 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,207 | 3,526 | 4,863 | 0 | 0 |
| Accrued Expenses | 29,057 | 25,058 | 25,568 | 0 | N/A |
| Other current liabilities | 9,486 | 25,116 | 25,006 | 0 | N/A |
| TOTAL | $46,738 | $59,281 | $63,663 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,988 | 5,581 | 8,226 | N/A | N/A |
| Other Non-Current Liabilities | 71,216 | 70,696 | 62,371 | 0 | 0 |
| TOTAL | $150,881 | $152,579 | $144,249 | $N/A | $N/A |
| Total Liabilities | $197,619 | $211,860 | $207,912 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,269 | 12,024 | 11,970 | N/A | N/A |
| Common Shares | 24 | 24 | 24 | 0 | N/A |
| Retained earnings | -584,362 | -500,656 | -451,781 | 0 | N/A |
| Other shareholders' equity | -1,623 | -65 | 73 | 0 | 0 |
| TOTAL | $929,787 | $986,474 | $1,021,955 | $0 | $N/A |
| Total Liabilities And Equity | $1,127,406 | $1,198,334 | $1,229,867 | $0 | $0 |